Radioactive Iodine Therapy: Radiation Safety for Family Members

Radioactive iodine (I-131) treatment for thyroid cancer involves temporary radiation exposure to close contacts. Modern protocols minimize risk through:

Safety Measures

• Patient isolation: Private room (1–3 days) until dose rate <7 mrem/hr at 1 meter.
• Time, distance, shielding: Visitors limited; pregnant women/children restricted.
• Bodily fluid precautions: Flush toilet 2–3×; separate utensils/towels; no shared food.
• Sleep separation: Separate bed ≥6 ft for 3–7 days post-discharge.
• Hygiene: Daily showers; launder linens separately.

Dose to Spouse

Typical cumulative dose to a compliant spouse: 0.1–0.5 rem (1–5 mSv)—well below the 5 rem/yr public limit and far below thresholds for deterministic effects. Long-term stochastic risk is negligible.

Follow-Up

• Whole-body scan at 2–7 days post-therapy.
• Thyroglobulin monitoring.
• TSH suppression therapy.

Strict adherence to radiation safety instructions ensures family protection. The treating nuclear medicine team provides personalized guidelines based on administered activity.